MEDA __ (2,500 mg. /kg. bodyweight). These results are shown in Fig. 3 . It is clear that the increased dosage has greatly increased the effectiveness of the treatment.
Discussion
The results obtained show that this compound is effective in the treatment of Staph. pyogenes infections in mice. When its activity was compared with other antibiotics it was less active than erythromycin and of comparable activity to chloramphenicol and streptomycin. However, in the case of erythromycin it is worth noting that 50 mg. /kg. is a large dose, and a comparatively small increase would be apt to give rise to toxic symptoms in the animals, but the dosage of BRL 1241 could be greatly increased without risk of intoxication (Brown and Acred, 1960) . The surprisingly satisfactory response to streptomycin in view of the in vitro resistance of the organism to this drug may be explained by the fact that the intracellular streptomycin level is only about one-tenth that of the extracellular level (Mackaness, 1952), and consequently the extracellular level (in effect the therapeutic level) would be effective in combating the infection.
The exceedingly low toxicity of BRL 1241 (mice have been given single inoculations of 0.5 g. without ill effect) prompted us to try the therapeutic effect of doses in excess of 50 mg./kg. bodyweight. The most striking feature of this experiment was that single doses of 50 mg. per 20-g. mouse (2,500 mg. /kg.) was curative, while the same total dosage divided into five daily doses of 10 mg. per mouse was only slightly less effective (Fig. 3) . It would appear that it is better to treat infections with a single overwhelming dose of this drug. No experiments have been done in animals using penicillin-sensitive strains of Staph. pyogenes, but since found no strains resistant to BRL 1241 among a wide range examined it seems unlikely that treatment of these would be any less effective. Summaqy BRL 1241 is shown to be effective in the treatment of penicillin-resistant staphylococcal infections in mice.
The results of treatment with the drug are compared with results obtained in the treatment of similar infections with antibiotics in common use.
We The isolation of pure 6-aminopenicillanic acid has made it possible to synthesize a large number of penicillin compounds by the substitution of different radicals on the side-chain of the penicillanic acid nucleus. One such compound, BRL 1241 (" celbenin '), is of special interest in that it is virtually non-toxic, has an antibiotic spectrum similar to penicillin itself, is not destroyed by staphylococcal penicillinase, and is active against staphylococcal infections in vivo .
We have compared the activity of compound BRL 1241 with crystalline penicillin G against all isolations of Staphylococcus pyogenes in this hospital in the ninemonths period between June, 1959, and April, 1960 .
Materials and Methods

Staphylococcus pyogenes
All coagulase-positive staphylococci were regarded as Staph. pyogenes and the organisms were subcultured on to broth-agar slopes for storage purposes at the time of isolation. The strains examined were all isolated from the patients and staff of this hospital between June, 1959, showed that the growth of the organisms was inhibited by a concentration of between 2 and 3 ug. of the compound per nil. A solution of comparable activity to one containing 6 pg. of crystalline penicillin G per ml. was therefore prepared containing 1.25 mg. of compound BRL 1241 per ml. in distilled water.
Methods of Sensitivity
Qualitative tests were carried out on broth-agar of uniform composition and poured in 12-ml. amounts into flat-bottomed disposable polystyrene Petri dishes 85 mm. in diameter. These plates were dried before use. Two strips of filter paper 65 by 5 mm. were impregnated, one with crystalline penicillin G and the other with compound BRL 1241, and placed upon plates pre-inoculated with streaks of six strains of staphylococci. The filter paper was placed at right angles to the line of inoculation and the two strips were well separated. The result was recorded after overnight incubation at 370 C. by measuring the diameter of the zones of inhibition of the cultures by superimposing the culture plates on 1-mm. graph paper.
Subsequently the sensitivity to compound BRL 1241 of groups containing the most sensitive and least sensitive strains as assessed by the inhibition zone diameters, which ranged from 19 mm. to 5 mm., was determined quantitatively by the method of Selbie et al. (1945) to establish the effective range of the compound against staphylococci.
Results A total number of 1,118 isolations of pathogenic staphylococci were examined. All of these proved sensitive to compound BRL 1241, whereas only 202 (18%) were sensitive to crystalline penicillin G. All the organisms were sensitive to compound BRL 1241 in concentrations between 1.6 and 3.2 pg./ml. It is worthy of note that whereas 20% of staphylococci examined at the time of introduction of penicillin (Selbie et al., 1945) were resistant to the antibiotic, we have found no strains of Staph. pyogenes resistant to compound BRL 1241 on its introduction. However, previous experience with antibiotics in general use has shown that, sooner or later, resistant strains of staphylococci appear and, having appeared, increase steadily in the hospital environment. So far, we have not encountered a strain of staphylococcus which is resistant to compound BRL 1241 ; but while it is possible that such a strain will appear, with proper control of the therapeutic use of compound BRL 1241 the number of resistant strains will be kept at a low level.
